The content of the invention
It is an object of the invention to provide a kind of high yield pulp1, the preparation technology of the rabies human immunoglobulin of high-purity.
The present invention is achieved like this, a kind of rabies human immunoglobulin preparation technology, and it includes low temperature second successively
Alcohol filter press technique, chromatography, ultrafiltration, nanof iotaltration and washing, drying and pouring linkage layered water flood well technology extract separating immune globulin,
Chromatography is a step ion exchange chromatography, and the supernatant of component III, then the supernatant of refined component III to obtaining first are refined before chromatography
Liquid parameter is adjusted, and the protein concentration of the supernatant of refined component III is adjusted to 3~6%, pH to 6.4~6.6, and electrical conductivity exists
It is 0.18~0.22s/m to be surveyed at T=19 DEG C, carries out purified by column chromatography after regulating with ion exchange column, and chromatography uses DEAE
Sepharose FF fillers;It is 3.8~4.0 that chromatography is finished and adjust again pH.
Its concrete technology scheme is as follows:
(1), by the centrifugation of the human plasma that it is qualified that quarantine quarantines, be centrifuged out liquid temperature control at 0 ~ 4 DEG C;Separate cryoprecipitate,
Cryoprecipitate is produced for VIII factor, and its supernatant is delivered into Protein Separation retort, make the temperature of protein liquid 1~3 DEG C it
Between, it is 6.70~7.20 to be slowly added to pH4.0 acetate buffer solutions regulation pH value;Plus less than -15 DEG C of 95% or 50% ethanol, make
Ethanol final concentration is to 8%(V/V), at -1~-3 DEG C, pH value is 6.80~7.20 to temperature control after adding ethanol;
(2), by step(1)Prepared thing stirring more than 30min, be centrifuged, be centrifuged out liquid temperature control -1~-3
DEG C, component I precipitations and components I supernatant is centrifuged to obtain;Component I precipitations deposit in freezer or are directly used in fibrin original production;
(3), by step(2)Prepared thing component I supernatants add pH4.0 acetate buffer solutions, regulation pH value to 6.7~
6.9;Plus less than -15 DEG C of 95% ethanol to concentration of alcohol is 20%(V/V), temperature control is at -4~-6 DEG C;After adding ethanol
PH should be 6.80~7.00;After stirring more than 120min, more than 60min is stood, be then turned on stirring, added by every liter of reaction solution
18g diatomite, carries out press filtration, and press filtration obtains the precipitation of compositionⅱ+III and the supernatant of compositionⅱ+III, and the supernatant of compositionⅱ+III is used for people
Blood albumin is produced;
(4), by step(3)Prepared thing compositionⅱ+III precipitation, add 10~15 times amount waters for injection, adjusted with NaCl
Whole its Na ion concentration is 0.01mol/L;Stirring is opened, 3~5 DEG C are cooled to, the precipitation of compositionⅱ+III is poured into retort and is stirred
Mix dissolving;PH4.0 acetate buffer solutions are slowly added in whipping process in reaction solution, adjustment pH is 5. 80~5.85, reaction
Liquid temperature degree is 0~-1 DEG C, adds buffer solution, continues to stir at least 10min;Open 95% second below kind of refrigeration cycle, plus -15 DEG C
Alcohol, makes the final concentration of alcohol of reaction solution be 19%;Reaction solution final temperature is controlled at -4~-6 DEG C, is added ethanol and is continued to stir
2h, stands more than 4h and is compressed filtering;First the compressed air below -4 DEG C of use slowly blows out the water in filter, starts retort
Agitator, makes diatomite mix more than 10min with reaction solution and filters while stirring, and it is -4 that liquid temperature degree is kept out in filter process
~-6 DEG C, filter pressure is no more than 0.2Mpa, collects refined compositionⅱ+III and precipitates;
(5), by step(4)The refined compositionⅱ+III of prepared thing precipitate, add 10~15 times of waters for injection of amount, use
NaCl adjusts its Na ion concentration for 0.01mol/L;Stirring is opened, when being cooled to 2~4 DEG C, refined compositionⅱ+III precipitation is fallen
Enter stirring and dissolving in retort;PH4.0 acetate buffer solutions are slowly added in whipping process in reaction solution, adjustment pH is 5.1
~5.4, reacting liquid temperature is 0~-1 DEG C, adds buffer solution, continues to stir at least 10min;Open kind of refrigeration cycle, plus -15 DEG C with
Under 95% ethanol, make the final concentration of alcohol of reaction solution be 17%;Reaction solution final temperature is controlled at -5~-7 DEG C, and pH is 5.2
~5.4, add ethanol and continue to stir 2h, stand more than 4h and be compressed filtering;First the compressed air below -5 DEG C of use is slowly blown
The water gone out in filter, starts reaction jar agitator, diatomite is mixed more than 10min with reaction solution and filters while stirring, in mistake
Liquid temperature degree is kept out during filter for -5~-7 DEG C, the precipitation of component III and the supernatant of component III is obtained;
(6)By step(5)The prepared supernatant of thing component III metering after, start reaction jar agitator and kind of refrigeration cycle, control
Temperature processed is -5~-7 DEG C, carries out in-depth filtration, filters out liquid temperature control at -5~-7 DEG C, with 1.0mol/L's after filtering
HCl regulations pH is 4.0 or so;Protein concentrate concentration is dialysed to more than 5% with 5 times of volumes, 2~8 DEG C of waters for injection, dialysis
Obtain final product the supernatant of refined component III;Protein concentration is adjusted to 3~6%, pH to 6.4~6.6 is adjusted with the NaOH of 0.5mol/L, so
Afterwards plus 1mol/L phosphoric acid-NaOH buffer solutions regulation electrical conductivity is surveyed at T=19 DEG C be 0.18~0.22s/m, use ion after regulating
Exchange column carries out purified by column chromatography, and chromatography uses DEAE Sepharose FF fillers;Chromatography is finished with the HCl of 1.0mol/L
Regulation pH be 3.8~4.0, open ultrafilter be concentrated into more than 5%, dialysed with 2~8 DEG C of waters for injection, make ethanol content≤
0.025%, protein liquid is then concentrated into more than 6%, the maltose of amount of calculation is added in protein liquid, with the HCl of 1.0mol/L
Regulation pH value, makes maltose content 10 ± 1%, and pH is 3.9~4.3, protein content 5.5 ± 0.5%;
(7), by step(6)Prepared thing prepare after protein liquid in carrying out aseptic filtration in 6h;Product after aseptic filtration
Incubated at low pH room is placed on, through 24 ± 1 DEG C of incubated at low pH 21 days;Incubate and remove virus filtration with DV50 filter cores after putting end;
(8), by step(7)Prepared thing filtering after protein liquid, with 2~8 DEG C of 0.85%NaCl solution ultrafiltration, carry out five
Times isometric washing, washing terminate after concentration, it is dilute match somebody with somebody, adjustment glycine is 26~30g/L, adjustment product pH value for 6.6~
7.2, rabies antibody potency >=100IU/mL;
(9), by step(8)Prepared thing dilute dispensed through 0.2 μm of degerming filter element filtering with protein liquid;Product after packing send
Inspection, lamp inspection, pack, are put in storage after the assay was approved;
In addition to having and limiting, remaining is mass percent to the percentage.
The aqueous solution that the pH4.0 acetate buffer solutions are made up of sodium acetate and glacial acetic acid, 244.9mL is added in every liter of water
Mass concentration is 99% glacial acetic acid and 65.6g sodium acetates.
Component I supernatants and its precipitation, the supernatant of compositionⅱ+III and its precipitation are the universal classification of art
Method;It is also in the present invention the title by material after universal classification classification, does not imply that simple sequence number.
Cryoprecipitate is centrifuged by human plasma, the centrifuged supernatant after separation adds second by adjusting pH and temperature
Alcohol is centrifuged to obtain component I supernatants and its precipitation again;
By adjusting pH and temperature to component I supernatants, press filtration obtains the supernatant of compositionⅱ+III and its sinks addition ethanol again
Form sediment;
Component I precipitations mainly contain fine former, FV III, Ciq, Clr, Cls and fibronectin etc.;
Component I supernatants are mainly contained:Albumin, IgG, IgA, IgM, F II, VII, Ⅸ, Ⅹ, α, beta Globulin, covellite egg
In vain, alpha1-antitrypsin, the complement component of IgM, AT- III, transferrins, haptoglobin etc.;
The precipitation of compositionⅱ+III mainly contains IgG, IgA, IgM, F II, VII, Ⅸ, Ⅹ, α, beta Globulin and CER etc.;
The supernatant of compositionⅱ+III is mainly contained:Albumin, α, beta Globulin, CER, alpha1-antitrypsin, IgM,
The complement components of AT- III, transferrins, haptoglobin etc..
The positive effect of the present invention:
The present invention combines optimize technique, using cold ethanol press filtration extraction and separation technology and a step ion-exchange chromatography
(Chromatogram)Technology is combined to extract to separate and obtains rabies human immunoglobulin, while removing disease using secondary Viral inactivation techniques
Poison, can effectively improve product recovery rate, improve the purity and its security of product.Specially:
1st, using cold ethanol filter press technique, chromatography, ultrafiltration, the technique skill such as nanof iotaltration and washing, drying and pouring linkage packing
Art, and through effective viral inactivation treatment, it is mature technology, stabilization, advanced.
2nd, clinical efficacy it is clear and definite, safe, can rapidly symptom management progress and epidemic situation development, while dosage it is small,
Quiet third is reduced using so as to save rare blood plasma resource.
3rd, SIG derives from healthy human body, and its structure is safe without any transformation and modification, makees
With clear and definite, the R&D cycle is relatively short, and pharmacological effect effect is clear and definite, relatively easily goes out product, produces result.
Compared to the preparation technology of rabies human immunoglobulin compared to existing technology, innovative point is the present invention:
1st, by cold ethanol method below -15 DEG C of multistep, refine step by step, joined by adjusting temperature, PH, ionic strength etc.
Number, makes whole concentration of alcohol obtain component I supernatants, the precipitation of compositionⅱ+III, refined compositionⅱ for 8%, 20%, 19%, 17% successively
+ III precipitation, the supernatant of component III, and carry out filter pressing it is standby go out purity more than 95.0%, IgG monomers and dimer total content exist
More than 92.0% rabies human immunoglobulin.Remaining ingredient can be used for the production of other blood products simultaneously.
2nd, prior art is such as《High-purity rabies human immunoglobulin and its feedstock production process》
CN200710114839.8 is carried out pure using Q-Sepharose FF and DEAE Sepharose FF two step ion exchange chromatographies methods
Change.Before present invention optimization chromatography the refined Supernatant protein liquid of component III be concentration 3~6%, pH6.4~6.6, electrical conductivity 0.18~
0.22 s/m(T=19℃)Etc. upper prop purifying again after response parameter, chromatography finish again with 1.0mol/L HCl adjust pH 3.8~
4.0.One step ion exchange equally can effectively remove foreign protein, improve purity, and by ultrafiltration, concentration, addition maltose is protected
The rabies human that the methods such as shield agent obtain the moderate purity 99.5% of the embodiment of the present invention 1, IgG monomers and dimer total content 98.8% is immunized
Globulin liquid.The use of maltose, can protect immunoglobulin molecules functional characteristic not influenceed by temperature and time.Compared to
Two step ion-exchanges, step chromatography and addition protective agent simple possible, save operation, reduce production cost.
3rd, the present invention obtains the various process parameters such as optimal column chromatography by experiment, and the technique can produce 200IU/ bottles
Bottle/ton the blood plasma of rabies human immunoglobulin 17887, compared to the conventionally produced bottle/ton blood of immunoglobulin 15000
Slurry, the present invention can produce 2887 bottle/ton blood plasma more, and recovery rate can improve 19.2 ~ 25% compared with traditional handicraft.
The inventive method prepare product with《Chinese Pharmacopoeia》(Version in 2010, three)Described in the immune ball of rabies human
Contrast such as following table of the albumen in Key Quality Indicator.
Embodiment 1:By taking 5000 liters of blood plasma as an example, specific preparation technology is as follows:
(1), quarantine is quarantined qualified 5000 liters of human plasmas centrifugation, be centrifuged out liquid temperature control at 0 ~ 4 DEG C;Separate cold
Precipitation, cryoprecipitate is produced for VIII factor, is taken its supernatant and is delivered to Protein Separation retort, and the temperature control of protein liquid is existed
Between 1~3 DEG C, it is 6.70~7.20 to be slowly added to pH4.0 acetate buffer solutions regulation pH value;Plus less than -15 DEG C 95% or
50% ethanol, makes ethanol final concentration to 8%(V/V), temperature control at -1~-3 DEG C, add pH value after ethanol should be 6.80~
7.20;The aqueous solution that the pH4.0 acetate buffer solutions are made up of sodium acetate and glacial acetic acid, adds 244.9mL matter in every liter of water
Amount concentration is 99% glacial acetic acid and 65.6g sodium acetates.
(2), by step(1)Prepared thing stirring more than 30min, be centrifuged, be centrifuged out liquid temperature control -1~-3
DEG C, component I precipitations and components I supernatant is centrifuged to obtain;Component I precipitations deposit in freezer or are directly used in fibrin original production.
(3), by step(2)Prepared thing component I supernatants add pH4.0 acetate buffer solutions in, adjust supernatant pH value
To 6.7~6.9;Plus less than -15 DEG C of 95% ethanol to concentration of alcohol is 20%(V/V), temperature control is at -4~-6 DEG C;Add
PH should be 6.80~7.00 after ethanol;After stirring more than 120min, more than 60min is stood, open stirring, added by every liter of reaction solution
Enter 18g diatomite, carry out press filtration, inlet hydraulic not more than 0.20Mpa, press filtration obtains the precipitation of compositionⅱ+III and compositionⅱ+III
Supernatant, the supernatant of compositionⅱ+III is produced for human serum albumin.
(4), by step(3)Prepared thing compositionⅱ+III precipitate 467 kilograms, add 13 times amount waters for injection, use NaCl
Its Na ion concentration is adjusted for 0.01mol/L;Stirring is opened, when being cooled to 3~5 DEG C, the precipitation of compositionⅱ+III retort is poured into
Middle stirring and dissolving;PH4.0 acetate buffer solutions are slowly added in whipping process in reaction solution, adjustment pH is 5. 80~5.85,
Reacting liquid temperature is 0~-1 DEG C, adds buffer solution, continues to stir at least 10min;Open below kind of refrigeration cycle, plus -15 DEG C
95% ethanol, makes the final concentration of alcohol of reaction solution be 19%;Reaction solution final temperature is controlled at -4~-6 DEG C, adds ethanol continuation
Stirring 2h, stands more than 4h and is compressed filtering;First the compressed air below -4 DEG C of use slowly blows out the water in filter, starts anti-
Jar agitator is answered, diatomite is mixed more than 10min with reaction solution and is filtered while stirring, liquid temperature degree is kept out in filter process
It is -4~-6 DEG C, filter pressure is no more than 0.2Mpa, collects refined compositionⅱ+III and precipitate.
(5), by step(4)The refined compositionⅱ+III of prepared thing precipitate 440 kilograms, add 13 times of waters for injection of amount, use
NaCl adjusts its Na ion concentration for 0.01mol/L;Stirring is opened, when being cooled to 2~4 DEG C, refined compositionⅱ+III precipitation is fallen
Enter stirring and dissolving in retort;PH4.0 acetate buffer solutions are slowly added in whipping process in reaction solution, adjustment pH is 5. 1
~5.4, reacting liquid temperature is 0~-1 DEG C, adds buffer solution, continues to stir at least 10min;Open kind of refrigeration cycle, plus -15 DEG C with
Under 95% ethanol, make the final concentration of alcohol of reaction solution be 17%;Reaction solution final temperature is controlled at -5~-7 DEG C, and pH is 5.2
~5.4, add ethanol and continue to stir 2h, stand more than 4h and be compressed filtering;First the compressed air below -5 DEG C of use is slowly blown
The water gone out in filter, starts reaction jar agitator, diatomite is mixed more than 10min with reaction solution and filters while stirring, in mistake
It is -5~-7 DEG C that liquid temperature degree is kept out during filter;Obtain the precipitation of component III and the supernatant of component III;
(6), by step(5)The prepared supernatant of thing component III metering after, start reaction jar agitator and kind of refrigeration cycle, control
Temperature processed is -5~-7 DEG C, carries out in-depth filtration, filters out liquid temperature control at -5~-7 DEG C, with 1.0mol/L's after filtering
HCl regulations pH is 4.0 or so;8563 kilograms of protein liquids are obtained after regulation PH, protein concentration more than 5% is concentrated into, volume after must concentrating
600 liters, dialysed with 5 times of volumes, 2~8 DEG C of waters for injection, dialysis obtains final product the supernatant of refined component III;Protein concentration is adjusted
To 5.9%, pH to 6.53 is adjusted with the NaOH of 0.5mol/L, then add 1mol/L phosphoric acid-NaOH buffer solutions to adjust electrical conductivity in T=19
DEG C when to survey be 0.194s/m, carry out purified by column chromatography after regulating with ion exchange column, chromatography uses DEAE Sepharose
FF fillers;It is 3.8~4.0 that chromatography is finished and adjusts pH with the HCl of 1.0mol/L, opens ultrafilter and is concentrated into more than 5%, with 2~8
DEG C water for injection is dialysed, and makes ethanol content≤0.025%, protein liquid then is concentrated into more than 6%, by the malt of amount of calculation
Sugar is added in protein liquid, and with the HCl regulation pH value of 1.0mol/L, maltose content 9.7% in final protein liquid, pH is 4.10, egg
Bai Hanliang 6.0%, 478.5 kilograms of solution weight.
(7), by step(6)Prepared thing prepare after 478.5 kilograms of protein liquid in carrying out aseptic filtration in 6h;Degerming mistake
Product was placed on incubated at low pH room after filter, through 24 DEG C of ± 1 DEG C of incubated at low pH 21 days;Incubate and remove viral mistake with DV50 filter cores after putting end
Filter;
(8), by step(7)Prepared thing filtering after protein liquid, with 2~8 DEG C of 0.85%NaCl solution ultrafiltration, carry out five
Times isometric washing, washing terminate rear protein concentration to 14.4% carry out it is dilute match somebody with somebody, adjustment glycine is 27g/L, adjustment product pH value
It is 6..8, rabies antibody potency >=100IU/mL.
(9), by step(8)Prepared thing it is dilute with protein liquid 185.4 kilograms carry out protein filtering, mistake through 0.2 μm of filter core
183.2 kilograms of albumen liquid measure is obtained after filter;Packing, packing loading amount is every bottle of 2mL, and packing quantity is 89438 bottles;Product after packing
Censorship, lamp inspection, pack, are put in storage after the assay was approved.
In addition to having and limiting, remaining is mass percent to the percentage.
The verification result of the product prepared through the present embodiment is referring to table 1 below~table 4.
As can be seen from the table, the rabies human immunoglobulin purity that embodiment is prepared is more than 95.0%
(99.5%), IgG monomers and dimer total content be more than 92.0%(98.8%).
The molecular size distribution results scanning figure for preparing product is shown in Fig. 2 and Fig. 3.
The purity result scanning figure for preparing product is shown in Fig. 4.
Table 1:Heat stabilization test
Table 2:Molecular size measure of spread
Table 3:Protein content determination
Table 4:Purity testing